Gennex Laboratories Limited
Gennex Laboratories Limited
Share · INE509C01026 (XBOM)
Overview
No Price
Closing Price XBOM 29.01.2026: 12,16 INR
29.01.2026 09:59
Current Prices from Gennex Laboratories Limited
ExchangeTickerCurrencyLast TradePriceDaily Change
XBOM: MSE
MSE
GENNEX.BO
INR
29.01.2026 09:59
12,16 INR
-0,10 INR
-0,82 %
Share Float & Liquidity
Free Float 40,55 %
Shares Float 98,52 M
Shares Outstanding 242,95 M
Company Profile for Gennex Laboratories Limited Share
Gennex Laboratories Ltd. engages in the manufacture of bulk drugs, intermediates and biotech products. It operates through the following geographical segments: Germany, Egypt, Iran, Peru, Spain, Guatemala City, South Korea, Vietnam, Export Others, and India. The company was founded on March 29, 1990 and is headquartered in Hyderabad, India.
AI Analysis of Gennex Laboratories Limited
Click any analysis below to get instant AI insights from finAgent
Latest AI Analyses of Gennex Laboratories Limited
No AI threads available for this company yet.

Company Data

Name Gennex Laboratories Limited
Company Gennex Laboratories Limited
Website http://www.gennexlab.com
Primary Exchange XBOM MSE
ISIN INE509C01026
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Arihant Baid
Market Capitalization 3 Mrd.
Country India
Currency INR
Employees 0,1 T
Address Plot No. 144, Akash Ganga Complex, Hyderabad
IPO Date 2001-04-26

Ticker Symbols

Name Symbol
MSE GENNEX.BO
More Shares
Investors who hold Gennex Laboratories Limited also have the following shares in their portfolio:
CASCADE COPPER
CASCADE COPPER Share
NOKIA OYJ 19/26 MTN
NOKIA OYJ 19/26 MTN Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026